Journal Articles
HIV medicine
Year : 2017
Gestionnaire HAL 4 Sorbonne Université : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-03703933
Submitted on : Friday, June 24, 2022-2:13:07 PM
Last modification on : Thursday, December 14, 2023-1:50:38 PM
Cite
Pm Girard, A Antinori, J. R. Arribas, D Ripamonti, C Bicer, et al.. Week 96 Efficacy and Safety of Darunavir/Ritonavir Monotherapy vs. Darunavir/Ritonavir with Two Nucleoside Reverse Transcriptase Inhibitors in the PROTEA Trial. HIV medicine, 2017, 18 (1), pp.5--12. ⟨10.1111/hiv.12386⟩. ⟨hal-03703933⟩
Collections
9
View
0
Download